Skip to main content
. 2017 Jan 11;22(3):494–504. doi: 10.1007/s10147-016-1083-9

Table 7.

Adverse events in the 12M group during cycles 1–8 and 9–16

During cycles 1–8 (n = 636) During cycles 9–16 (n = 417)
Any grade (%) Grade ≥3 (%) Any grade (%) Grade ≥3 (%)
Hemoglobin 34.9 0 31.7 0.5
Leukocytes 19.3 0.3 21.1 0
Neutrophils 17.6 2.8 12.9 2.2
Platelets 9.6 0.5 12.7 0
Total bilirubin 32.5 0.6 36.0 0.5
AST 16.2 0.3 17.5 0.5
ALT 15.4 0.3 14.1 0.2
Creatinine 5.2 0 7.7 0
Anorexia 18.4 0.9 9.1 0
Nausea 12.4 0.6 4.1 0
Vomiting 4.2 0.5 1.7 0
Stomatitis 18.9 0.9 10.6 0
Diarrhea 11.6 1.7 6.7 0.5
Fatigue 13.1 0.9 7.9 0.5
Rash 7.5 0.2 6.7 0
Hyperpigmentation 20.8 0.5 18.7 0
Alopecia 1.9 0 1.4 0.2
Hand-foot syndrome 71.1 19.0 66.7 8.6

AST aspartate aminotransferase, ALT alanine aminotransferase